체코 -
체코어 -
SUKL (Státní ústav pro kontrolu léčiv)
lacosamide zentiva 50mg potahovaná tableta
zentiva, k.s., praha array - 16489 lakosamid - potahovaná tableta - 50mg - lakosamid
체코 -
체코어 -
SUKL (Státní ústav pro kontrolu léčiv)
lakosamid +pharma 100mg potahovaná tableta
+pharma arzneimittel gmbh, graz array - 16489 lakosamid - potahovaná tableta - 100mg - lakosamid
체코 -
체코어 -
SUKL (Státní ústav pro kontrolu léčiv)
lakosamid +pharma 150mg potahovaná tableta
+pharma arzneimittel gmbh, graz array - 16489 lakosamid - potahovaná tableta - 150mg - lakosamid
체코 -
체코어 -
SUKL (Státní ústav pro kontrolu léčiv)
lakosamid +pharma 200mg potahovaná tableta
+pharma arzneimittel gmbh, graz array - 16489 lakosamid - potahovaná tableta - 200mg - lakosamid
체코 -
체코어 -
SUKL (Státní ústav pro kontrolu léčiv)
lakosamid +pharma 50mg potahovaná tableta
+pharma arzneimittel gmbh, graz array - 16489 lakosamid - potahovaná tableta - 50mg - lakosamid
체코 -
체코어 -
SUKL (Státní ústav pro kontrolu léčiv)
midza 100mg potahovaná tableta
belupo lijekovi i kozmetika, d.d., koprivnica array - 16489 lakosamid - potahovaná tableta - 100mg - lakosamid
체코 -
체코어 -
SUKL (Státní ústav pro kontrolu léčiv)
midza 150mg potahovaná tableta
belupo lijekovi i kozmetika, d.d., koprivnica array - 16489 lakosamid - potahovaná tableta - 150mg - lakosamid
체코 -
체코어 -
SUKL (Státní ústav pro kontrolu léčiv)
midza 200mg potahovaná tableta
belupo lijekovi i kozmetika, d.d., koprivnica array - 16489 lakosamid - potahovaná tableta - 200mg - lakosamid
체코 -
체코어 -
SUKL (Státní ústav pro kontrolu léčiv)
midza 50mg potahovaná tableta
belupo lijekovi i kozmetika, d.d., koprivnica array - 16489 lakosamid - potahovaná tableta - 50mg - lakosamid
유럽 연합 -
체코어 -
EMA (European Medicines Agency)
lacosamide adroiq
extrovis eu ltd. - lakosamid - epilepsie - antiepileptika, - lacosamide adroiq is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. lacosamide adroiq is indicated as adjunctive therapyin the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. in the treatment of primary generalised tonic-clonic seizures in adults, adolescents and children from 4 years of age with idiopathic generalised epilepsy.